Evaluation Of the BEAUTIBOND XTREME Adhesive in Class I and II Restorations: One-Year Results.
Launched by UNIVERSITY OF SAO PAULO · Mar 20, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 years or older
- • Occlusal stability supported by molars, Presence of at least one premolar or one molar with Class I/II cavities suitable for direct restoration or restoration replacement
- • Ability to attend evaluation and regular maintenance appointments
- • No clinical symptoms or radiographic signs suggesting pulp involvement
- • No periodontal pockets or compromised biological space invasion
- • Ability to perform absolute isolation of the operative field and subsequent restoration of the cavity with composite resin
- • Active carious lesion
- • Occlusal/occlusoproximal surface of molars and premolars, with a radiographic image showing shallow, medium, or deep dentin involvement, which is preventing the patient from effectively controlling bacterial biofilm, or showing some type of sensitivity
- • Cavity preparation margins (cavosurface) in enamel or dentin.
- Exclusion Criteria:
- • Poor oral hygiene control
- • Patients undergoing orthodontic treatment
- • Pregnant or lactating women
- • Oral complications such as: bruxism, other parafunctional habits reinforcing the diagnosis of TMD (temporomandibular disorders), periodontal problems
- • Pregnant or breastfeeding women
- • Presence of uncontrolled systemic diseases
- • Patients at high risk for caries.
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ribeirão Preto, São Paulo, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported